Genflow Biosciences: Funding, Investors & Team (Oct 2026)
GenFlow Biosciences is a synthetic biology corporation that creates gene therapies to delay or stop the aging process in both humans and canines. It is committed to the development and promotion of creative therapies that target aging in both humans and animals. Its main goals are extending life expectancy and creating treatments that can fight off diseases that are brought on by aging and advanced age.
Genflow Biosciences has raised $10.7M across 6 funding rounds on record, the most recent an undisclosed round of $1.1M announced in Mar 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genflow Biosciences Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Genflow Biosciences Funding Rounds
Genflow Biosciences raised $900k in an undisclosed round announced in Apr 2024.
6 months later, an undisclosed round of $3.0M was announced in Oct 2024.
7 months later, an undisclosed round of $670k was announced in May 2025.
2 months later, an undisclosed round of $4.6M was announced in Jul 2025.
3 months later, an undisclosed round of $460k was announced in Oct 2025.
5 months later, an undisclosed round of $1.1M was announced in Mar 2026.
Genflow Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Genflow Biosciences Funding Compared to Other Biotechnology Startups
Genflow Biosciences' latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genflow Biosciences in Biotechnology and Cambridge
Companies Similar to Genflow Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Genflow Biosciences Funding FAQs
What does Genflow Biosciences do?
GenFlow Biosciences is a synthetic biology corporation that creates gene therapies to delay or stop the aging process in both humans and canines. It is committed to the development and promotion of creative therapies that target aging in both humans and animals. Its main goals are extending life expectancy and creating treatments that can fight off diseases that are brought on by aging and advanced age.
How much funding has Genflow Biosciences raised?
Genflow Biosciences has raised $10.7M across 6 rounds on record. The most recent is an undisclosed round of $1.1M announced in Mar 2026.
When did Genflow Biosciences last raise funding?
Genflow Biosciences' most recent funding round on record is an undisclosed round of $1.1M, announced in Mar 2026.
Who founded Genflow Biosciences?
FundedIQ lists Eric Leire (Founder) at Genflow Biosciences.
Where is Genflow Biosciences headquartered?
Genflow Biosciences is based in Cambridge, Massachusetts, United States.
How many employees does Genflow Biosciences have?
Genflow Biosciences is in the 1-10 employee band.
How does Genflow Biosciences' funding compare to other Biotechnology startups?
Genflow Biosciences' latest round of $1.1M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Genflow Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genflow Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.